Related Experiment Video
Updated: May 23, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
The anticancer effects of resveratrol: modulation of transcription factors
Nichelle C Whitlock1, Seung Joon Baek
1Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee 37996, USA.
Abstract:
Resveratrol (3, 4', 5-trihydroxystilbene), a naturally occurring phytoalexin readily available in the diet, is reported to possess both chemopreventive and chemotherapeutic activities in several cancers. However, despite the identification of numerous molecular targets, the underlying mechanisms involved in the anticancer activities of resveratrol are not completely understood. Resveratrol is postulated to function as a potential signaling pathway modulator and, as such, is demonstrated to affect a multitude of signal transduction pathways associated with tumorigenesis and/or carcinogenesis; it is likely that this collective activity, rather than just a single effect, may play an important role in the anticancer properties of resveratrol. Since transcription factors control the expression of many genes, the elucidation of molecular targets of resveratrol involved in transcriptional regulation is necessary to better understand how this dietary phytochemical affects chemopreventive and chemotherapeutic processes. As a result, investigators have increasingly searched for and examined possible targets of resveratrol. In this review, we summarize the current knowledge on molecular targets, specifically transcription factors, that contribute to the observed anticancer effects of resveratrol related to 1) inhibition of carcinogenic activation and induction of carcinogen detoxification, 2) induction of growth arrest and apoptosis, and 3) suppression of proinflammatory signaling pathways related to cancer progression.
Insights
Resveratrol, a dietary compound, shows anticancer promise by modulating signaling pathways and transcription factors. Further research into these mechanisms is crucial for understanding its chemopreventive and chemotherapeutic potential in cancer.
Area of Science:
- Nutritional Biochemistry
- Molecular Oncology
- Cancer Prevention
Background:
- Resveratrol (3, 4', 5-trihydroxystilbene) is a natural phytoalexin found in the diet.
- It exhibits documented chemopreventive and chemotherapeutic effects across various cancers.
- The precise molecular mechanisms underlying resveratrol's anticancer activities remain incompletely elucidated.
Purpose of the Study:
- To review the current understanding of resveratrol's molecular targets, focusing on transcription factors.
- To elucidate how resveratrol influences transcriptional regulation in cancer chemoprevention and therapy.
- To consolidate knowledge on resveratrol's role in modulating key cancer-related signaling pathways.
Main Methods:
- Literature review of studies investigating resveratrol's molecular targets.
- Analysis of research on transcription factors affected by resveratrol.
- Synthesis of findings related to resveratrol's impact on carcinogenesis and cancer progression pathways.
Main Results:
- Resveratrol impacts multiple signal transduction pathways involved in tumorigenesis and carcinogenesis.
- Key molecular targets include transcription factors that regulate gene expression relevant to cancer.
- Resveratrol's anticancer effects are linked to inhibiting carcinogen activation, inducing detoxification, promoting growth arrest and apoptosis, and suppressing pro-inflammatory pathways.
Conclusions:
- Resveratrol's collective action on various molecular targets, particularly transcription factors, is critical for its anticancer properties.
- Understanding these targets is essential for optimizing resveratrol's use in chemoprevention and chemotherapy.
- This review highlights the significance of transcriptional regulation in resveratrol's multifaceted anticancer effects.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Transcription Factors
Transcription Factors
Co-activators and Co-repressors
Co-activators and Co-repressors
General Transcription Factors
